ym 09151-2 has been researched along with n-n-propylnorapomorphine in 2 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (n-n-propylnorapomorphine) | Trials (n-n-propylnorapomorphine) | Recent Studies (post-2010) (n-n-propylnorapomorphine) |
---|---|---|---|---|---|
249 | 6 | 13 | 274 | 4 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnt, J; Hyttel, J | 1 |
Matsumoto, A; Pauwels, PJ; Wurch, T | 1 |
2 other study(ies) available for ym 09151-2 and n-n-propylnorapomorphine
Article | Year |
---|---|
Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Drug Combinations; Male; Motor Activity; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1990 |
Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins.
Topics: Animals; Apomorphine; Bacterial Proteins; Benzamides; CHO Cells; COS Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Luminescent Proteins; Protein Structure, Quaternary; Receptors, Dopamine D2; Recombinant Fusion Proteins; Transfection | 2001 |